Interpace Diagnostics Group Inc. is issuing 2 million shares and 1.6 million pre-funded warrants to an undisclosed buyer to raise $1.7 million in net proceeds.

The shares are priced at 53 cents apiece while the warrants are exercisable at 52 cents per share.

Maxim Group LLC is the exclusive placement agent for the registered direct offering which is expected to close Dec. 22.

Funds raised will help Interpace meet working capital requirements.